I.H.J.T. De Hingh

Schafrat, P. J. M., van Erning, F. N., Zwinderman, K., Dekker, E., Farina Sarasqueta, A., de Vos-Geelen, J., Bouwense, S. A. W., Goedegebuure, R. S. A., Vermeulen, L., de Hingh, I. H. J. T., & Sommeijer, D. W. (2025). Malignancies of the small intestine: incidence and trends in a nationwide registry. Cancer Epidemiology, 99, Article 102943. https://doi.org/10.1016/j.canep.2025.102943

van der Ven, R., Westra, D., van Erning, F., de Hingh, I., Paulus, A., & OncoZON Consortium (2025). Organizing contemporary oncology care together - A scoping review on multi-hospital oncology networks. Journal of Cancer Policy, 46, Article 100651. Advance online publication. https://doi.org/10.1016/j.jcpo.2025.100651

Guchelaar, N. A. D., Tops-Welten, M. W., van der Sluis, P. C., Noordman, B. J., Koolen, S. L. W., Lagarde, S. M., Nieuwenhuijzen, G. A. P., de Neijs, M. J., van Hellemond, I. E. G., Luyer, M. D. P., Creemers, G. J., De Hingh, I. H. J. T., Mostert, B., Wijnhoven, B. P. L., & Mathijssen, R. H. J. (2025). Phase I study of intraperitoneal irinotecan with systemic capecitabine and oxaliplatin for patients with gastric peritoneal metastases. Biomedicine & Pharmacotherapy, 191, Article 118491. https://doi.org/10.1016/j.biopha.2025.118491

van Erning, F. N., Galanos, L. J. K., Lurvink, R., Aarts, M. J., van Hellemond, I. E. G., Nagtegaal, I. D., de Hingh, I. H. J. T., de Wilt, J. H. W., & Elferink, M. A. G. (2025). Socioeconomic differences among patients with stage I-III colon cancer: Detection, treatment and relative survival. International Journal of Cancer. Advance online publication. https://doi.org/10.1002/ijc.70181

van der Ven, R. G. F. M., van Erning, F. N., Westra, D. D., de Hingh, I. H. J. T., Paulus, A. T. G., Engelen, S. M. E., de Vries, B., Nieuwenhuijzen, G. A. P., & OncoZON Network (2025). Nationwide trends and the impact of an oncology hospital network on reducing the burden of thyroid cytology procedures. International Journal of Cancer, 157(6), 1120-1129. https://doi.org/10.1002/ijc.35462

van der Geest, L. G., van der Mark, M., Verheij, J., Farina Sarasqueta, A., de Vos-Geelen, J., Besselink, M. G., de Meijer, V. E., de Hingh, I. H. J. T., Bonsing, B. A., de Reuver, P. R., Willemssen, F. E. J. A., Vissers, P. A. J., Visser, O., & Dutch Pancreatic Cancer Group and the Dutch Hepatocellular & Cholangiocarcinoma Group (2025). Increased incidence, survival, and registration quality of primary hepato-pancreato-biliary cancers in the Netherlands Cancer Registry. International Journal of Cancer. https://doi.org/10.1002/ijc.70145

Tops-Welten, M. W., Galanos, L. J. K., Creemers, G.-J., Luyer, M. D. P., De Hingh, I. H. J. T., & van Hellemond, I. E. G. (2025). Gastrointestinal CancerEmerging treatment modalities for gastric cancer with peritoneal metastases: A systematic review. Oncologist, 30(9), Article oyaf219. https://doi.org/10.1093/oncolo/oyaf219

Constantinides, A., Lansu, N., Mosen, P., Rauwerdink, P., Strating, E., Vollmy, F., Nederend, M., Leusen, J. H. W., Rovers, K., Wassenaar, E., Lurvink, R., Altelaar, M., Nienhuijs, S., Wiezerf, R., Rinkesa, I. H. M. B., Boermaf, D., Kopsc, G. J. P. L., de Hingh, I., & Kranenburg, O. (2025). Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade. Translational Oncology, 59, Article 102464. https://doi.org/10.1016/j.tranon.2025.102464

van der Ven, R. G. F. M., Westra, D., van Erning, F. N., de Hingh, I. H., Paulus, A., & OncoZON Consortium (2025). Going in circles? - Identifying the dissemination process of healthcare networks within their member organizations. Social Science & Medicine, 381, Article 118311. https://doi.org/10.1016/j.socscimed.2025.118311

Galanos, L. J. K., Rijken, A., Elferink, M. A. G., Kok, N. F. M., van Erning, F. N., & De Hingh, I. H. J. T. (2025). Influence of a nationwide colorectal cancer screening program on the incidence of synchronous colorectal peritoneal metastases. International Journal of Cancer, 157(2), 232-238. https://doi.org/10.1002/ijc.35356